Carlo Tascini Selected Research

Linezolid (Zyvox)

1/2023	Linezolid Population Pharmacokinetics to Improve Dosing in Cardiosurgical Patients: Factoring a New Drug-Drug Interaction Pathway.
3/2015	Linezolid-resistant staphylococcal bacteraemia: A multicentre case-case-control study in Italy.
7/2013	Clinical pharmacokinetics of antibacterials in cerebrospinal fluid.
3/2011	Linezolid for endocarditis: a case series of 14 patients.
4/2010	A rapid high-performance liquid chromatography method to measure linezolid and daptomycin concentrations in human plasma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Carlo Tascini Research Topics

Disease

63	Infections 02/2024 - 09/2006
50	COVID-19 01/2024 - 01/2020
16	Endocarditis 03/2024 - 03/2011
15	Pneumonia (Pneumonitis) 01/2024 - 01/2016
14	Sepsis (Septicemia) 04/2024 - 03/2015
9	Septic Shock (Toxic Shock Syndrome) 04/2024 - 09/2015
9	Candidemia 07/2023 - 03/2015
7	Critical Illness (Critically Ill) 10/2020 - 12/2013
6	Healthcare-Associated Pneumonia 01/2024 - 05/2015
6	Urinary Tract Infections (Urinary Tract Infection) 11/2023 - 02/2009
5	Neoplasms (Cancer) 12/2023 - 01/2022
5	Respiratory Insufficiency (Respiratory Failure) 06/2023 - 07/2020
5	Fever (Fevers) 04/2023 - 04/2006
4	Bacteremia 01/2024 - 05/2011
4	Candidiasis (Moniliasis) 07/2023 - 12/2013
4	Inflammation (Inflammations) 08/2022 - 04/2008
4	Osteomyelitis 06/2021 - 09/2006
3	Cellulitis 01/2024 - 02/2011
3	Reinfection 12/2023 - 12/2021
3	Disease Progression 08/2023 - 07/2010
3	Virus Diseases (Viral Diseases) 11/2022 - 01/2019
3	Communicable Diseases (Infectious Diseases) 07/2022 - 12/2013
3	Cytokine Release Syndrome 01/2022 - 01/2020
3	Mycoses (Diseases, Fungus) 01/2022 - 11/2020
3	Meningitis 01/2021 - 04/2018
3	Malaria 11/2020 - 04/2006
3	Ventilator-Associated Pneumonia 01/2019 - 05/2015
2	Fatigue 02/2024 - 02/2021
2	Dyspnea (Shortness of Breath) 02/2024 - 02/2021
2	Gram-Positive Bacterial Infections 01/2024 - 12/2023
2	Hematologic Neoplasms (Hematological Malignancy) 01/2024 - 01/2023
2	Staphylococcal Infections 12/2023 - 02/2015
2	Cystitis 11/2023 - 01/2020
2	Bacterial Infections (Bacterial Infection) 08/2023 - 07/2019
2	Invasive Candidiasis 07/2023 - 12/2014
2	Thrombocytopenia (Thrombopenia) 05/2023 - 08/2020
2	Sinusitis 04/2023 - 09/2019
2	Obesity 04/2023 - 10/2022
2	Pulmonary Embolism 06/2022 - 02/2013
2	Coronavirus Infections 10/2021 - 06/2020
2	Renal Insufficiency (Renal Failure) 10/2021 - 04/2006

Drug/Important Bio-Agent (IBA)

16	Anti-Bacterial Agents (Antibiotics)IBA 08/2023 - 03/2013
12	Carbapenems (Carbapenem Antibiotics)IBA 08/2023 - 03/2013
12	Daptomycin FDA Link 01/2022 - 04/2010
10	Biomarkers (Surrogate Marker)IBA 11/2023 - 01/2020
8	Interleukin-6 (Interleukin 6)IBA 02/2024 - 11/2020
7	ceftobiproleIBA 03/2024 - 01/2019
7	Immunoglobulin M (IgM)IBA 12/2023 - 01/2018
7	CytokinesIBA 04/2022 - 11/2020
7	carbapenemaseIBA 11/2021 - 03/2013
6	beta-LactamsIBA 03/2024 - 06/2021
6	Immunoglobulin G (IgG)IBA 01/2024 - 10/2021
6	VaccinesIBA 12/2023 - 01/2020
6	Fosfomycin FDA Link 11/2023 - 05/2018
5	AminoglycosidesIBA 03/2024 - 01/2018
5	Antiviral Agents (Antivirals)IBA 10/2023 - 07/2010
5	AzolesIBA 07/2023 - 12/2013
5	Linezolid (Zyvox)FDA Link 01/2023 - 04/2010
5	Colistin (Coly-Mycin)FDA Link 01/2020 - 09/2006
4	dalbavancinIBA 01/2024 - 01/2021
4	Oxygen (Dioxygen)IBA 11/2023 - 02/2021
4	AnticoagulantsIBA 12/2021 - 01/2020
4	SteroidsIBA 09/2021 - 07/2010
3	Imipenem FDA Link 02/2024 - 09/2006
3	Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric 01/2024 - 01/2018
3	Monoclonal AntibodiesIBA 01/2024 - 12/2021
3	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2023 - 12/2015
3	Tromethamine (Trometamol)FDA Link 11/2023 - 01/2020
3	Ritonavir (Norvir)FDA Link 08/2023 - 06/2020
3	AntibodiesIBA 10/2022 - 12/2020
3	AdrenomedullinIBA 08/2022 - 01/2021
3	fibrin fragment D (D-dimer)IBA 06/2022 - 08/2020
3	ceftazidime drug combination avibactamIBA 11/2021 - 05/2018
3	Gentamicins (Gentamicin)FDA LinkGeneric 10/2021 - 01/2014
3	ProcalcitoninIBA 02/2021 - 01/2017
3	C-Reactive ProteinIBA 02/2021 - 08/2020
3	tocilizumab (atlizumab)FDA Link 01/2021 - 01/2020
3	Fluconazole (Zonal)FDA LinkGeneric 09/2018 - 12/2013
3	Biotin (Vitamin H)FDA Link 11/2010 - 04/2008
2	casirivimab and imdevimab drug combinationIBA 01/2024 - 11/2022
2	Cephalosporins (Cephalosporin Antibiotics)IBA 12/2023 - 01/2020
2	nirmatrelvir and ritonavir drug combinationIBA 10/2023 - 04/2023
2	Immunoglobulins (Immunoglobulin)IBA 10/2023 - 01/2018
2	molnupiravirIBA 10/2023 - 08/2023
2	Meropenem (Merrem)FDA LinkGeneric 08/2023 - 05/2018
2	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 06/2023 - 01/2023
2	Third Generation CephalosporinsIBA 02/2023 - 12/2017
2	cefditorenIBA 02/2023 - 01/2020
2	CefiderocolIBA 01/2023 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 08/2022 - 04/2008
2	Heparin (Liquaemin)FDA LinkGeneric 06/2022 - 08/2020
2	Amiodarone (Amiodarona)FDA LinkGeneric 10/2021 - 07/2020

Therapy/Procedure

52	Therapeutics 04/2024 - 09/2006
8	Artificial Respiration (Mechanical Ventilation) 01/2024 - 01/2019
5	Length of Stay 11/2023 - 07/2015
4	Critical Care (Surgical Intensive Care) 02/2022 - 12/2013
3	Noninvasive Ventilation 11/2023 - 01/2020
3	Mechanical Ventilators (Ventilator) 07/2023 - 01/2020
3	Continuous Renal Replacement Therapy 05/2020 - 01/2019
3	Central Venous Catheters 01/2020 - 03/2015